Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Syntara.
RELATED STOCKHEAD STORIES
Investor Guides
Investor Guide: Health & Biotech FY2025 featuring Tim Boreham
News
Rise and Shine: Everything you need to know before the ASX opens
News
Hot Money Tuesday: Momentum signals good entry points for Atlas Pearls, Andromeda, and AJ Lucas
News
Closing Bell: ASX down but smiles all round after surprise M&A Monday
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall but Dimerix up 150% on drug licensing deal
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX trips at starting gun while US Futures jump on world not ending yet
Health & Biotech
Move over Neuren – Bioshares reckons these ASX health stocks could pop with upcoming key catalysts
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall but don’t throw the baby out with the bathwater
Health & Biotech
ASX Health Stocks: Cannabis stock Little Green Pharma awarded French trial tender for CBD50
Health & Biotech
ASX biotechs are looking up, and the FDA breakthroughs are starting to flow
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall as investors fail to reward good news
Health & Biotech
Check Up: Here’s how diabetes drugs can help you get off the beers and lose weight
News
CLOSING BELL: A crazy ride for tech stocks and Wildcat as the ASX dips 0.22%
Experts
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
Experts
MoneyTalks: Brokers see blue sky for these 3 ASX biotech stocks, with massive price targets
Health & Biotech
